Alexander Y. Tokman, Director at ENDRA Life Sciences Inc. (NDRA), bought 20,000 shares at $0.26 ($5K) on 2022-08-22, disclosed to the SEC on 2022-08-24.
Open-market purchase of $5k NDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| NDRA | SELL | 2021-01-08 | $9K | — | Filing → |
| MVIS | BUY | 2016-12-14 | $100K | — | Filing → |
| MVIS | BUY | 2015-11-16 | $23K | — | Filing → |